Is the price fair?
What ELV's price assumes
Elevance Health trades at 17.8× earnings against 25.3× for the median Healthcare Plans name, cheaper than its own group.
17.8
Trailing P/E · Healthcare Plans median 25.3 · cheaper than the typical name in its group
- Price / sales
- 0.42
Price / sales · as of 2026-Q2
- Free cash flow yield
- 7.4%
Free cash flow yield · Healthcare Plans median 6.5%
- Growth the price implies
- +0.34%
Growth the price implies · The price pays for +0.34% free cash flow growth a year for a decade; the business has delivered −16% a year over the last three.
Details›
- Price / book2026-Q2
- 1.86
- EV / EBIToperating margin 2.7%: the multiple describes the denominator
- not meaningful
- EV / sales2026-Q2
- 0.52
- Healthcare median P/E362 names
- 31.5
- Healthcare Plans median P/E11 names
- 25.3
- Free cash flow, trailing twelve months
- $6.29B
- Market capitalisation
- $84.4B
- 3-year revenue growth
- +6.7%
- 3-year free cash flow growth
- −16%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $318.99 |
| Its own P/E history, median | $354.36 |
| Its own P/E history, upper quartile | $393.56 |
| 52-week range | $277.65 – $430.21 |
| Today | $402.55 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Healthcare Plans
Ranks #4 of 11 by Smart Score